Symptom-centric view

Gastrointestinal haemorrhage

Substances reporting Gastrointestinal haemorrhage disproportionately — ranked by ROR.

Pain Drug ineffective Off label use Fatigue Dyspnoea Acute kidney injury

showing 65 of 65

Substance ↓	ROR [95% CI]	Reports	Category	Label
warfarin sodium —	7.6 [7.2–8.1]	1,360	algemeen	new
warfarin —	6.7 [6.5–7.0]	3,273	algemeen	new
tranexamic acid —	3.6 [3.0–4.3]	125	algemeen	new
torsemide —	4.6 [4.2–5.0]	582	algemeen	new
tirofiban —	3.5 [2.6–4.8]	40	algemeen	new
ticagrelor —	5.4 [5.0–5.9]	674	algemeen	new
terazosin hydrochloride —	5.2 [4.5–6.0]	180	algemeen	new
terazosin —	5.2 [4.5–6.0]	180	algemeen	new
sucroferric oxyhydroxide —	2.9 [2.0–4.0]	34	algemeen	new
sucralfate oral suspension —	4.6 [4.1–5.3]	256	algemeen	new
sucralfate oral —	4.6 [4.1–5.3]	256	algemeen	new
sucralfate —	5.5 [5.1–6.0]	512	algemeen	new
sotatercept-csrk —	5.3 [4.3–6.6]	83	algemeen	new
sotalol hydrochloride —	6.1 [5.5–6.8]	395	algemeen	new
romiplostim —	2.8 [2.4–3.3]	167	algemeen	new
rivaroxaban —	39.0 [38.3–39.6]	21,611	algemeen	new
ramucirumab —	2.8 [2.2–3.6]	69	algemeen	new
propafenone —	5.0 [4.2–6.1]	108	algemeen	new
prasugrel hydrochloride —	12.2 [11.1–13.3]	470	algemeen	new
prasugrel —	11.2 [10.3–12.3]	534	algemeen	new
potassium chloride, dextrose monohydrate —	4.3 [4.1–4.5]	1,516	algemeen	new
potassium chloride oral —	4.3 [4.1–4.5]	1,516	algemeen	new
potassium chloride extended-release —	4.3 [4.0–4.5]	1,516	algemeen	new
potassium chloride —	4.5 [4.3–4.7]	2,088	algemeen	new
polyethylene glycol 3350, sodium sulfate anhydrous, sodium bicarbonate, sodium chloride, potassium chloride —	3.9 [2.5–6.1]	20	algemeen	new
olmesartan medoxomil-hydrochlorothiazide —	7.5 [6.5–8.5]	217	algemeen	new
nitroglycerin —	5.3 [5.0–5.6]	1,103	algemeen	new
metolazone —	7.7 [6.9–8.6]	334	algemeen	new
gilteritinib —	3.2 [2.4–4.2]	48	algemeen	new
gemtuzumab ozogamicin —	4.1 [3.2–5.3]	59	algemeen	new
furosemide —	4.7 [4.6–4.8]	6,908	algemeen	new
fondaparinux sodium —	4.8 [4.1–5.6]	152	algemeen	new
ferrous sulfate —	5.8 [5.4–6.1]	1,108	algemeen	new
ferrous asparto glycinate, iron, ascorbic acid, folic acid, cyanocobalamin, zinc, and succinic acid —	8.1 [5.1–12.8]	19	algemeen	new
etelcalcetide —	2.9 [2.0–4.0]	33	algemeen	new
ertugliflozin —	3.8 [2.4–6.0]	19	algemeen	new
enoxaparin sodium —	4.2 [3.9–4.5]	942	algemeen	new
emicizumab —	2.3 [1.9–2.8]	109	algemeen	new
edoxaban tosylate —	7.5 [6.5–8.7]	187	algemeen	new
dronedarone —	10.9 [9.8–12.0]	421	algemeen	new
dipyridamole —	5.3 [4.3–6.6]	83	algemeen	new
digoxin —	6.8 [6.5–7.2]	1,877	algemeen	new
defibrotide sodium —	8.8 [7.3–10.5]	121	algemeen	new
decitabine —	3.0 [2.4–3.9]	60	algemeen	new
daprodustat —	4.3 [3.0–6.1]	30	algemeen	new
dalteparin sodium —	4.9 [4.3–5.6]	202	algemeen	new
dabigatran etexilate mesylate —	33.2 [32.4–34.1]	7,869	algemeen	new
dabigatran etexilate —	32.5 [31.8–33.3]	8,323	algemeen	new
clopidogrel bisulfate —	6.6 [6.4–6.9]	2,549	algemeen	new
clopidogrel —	11.9 [11.6–12.1]	8,712	algemeen	new
cilostazol —	5.4 [4.5–6.4]	130	algemeen	new
carvedilol —	4.7 [4.5–4.9]	2,467	algemeen	new
bumetanide —	5.0 [4.6–5.5]	510	algemeen	new
bayer aspirin extra strength —	15.0 [13.1–17.2]	226	algemeen	new
aspirin enteric coated tablets 81mg —	7.2 [4.6–11.3]	20	algemeen	new
aspirin 81mg —	7.2 [4.6–11.3]	20	algemeen	new
aspirin 81 mg —	7.1 [7.0–7.2]	12,307	algemeen	new
aspirin 325mg —	7.2 [4.6–11.2]	20	algemeen	new
aspirin 325 mg —	7.1 [7.0–7.2]	12,299	algemeen	new
aspirin —	7.4 [7.2–7.5]	13,793	algemeen	new
apixaban —	6.4 [6.1–6.7]	1,600	algemeen	new
antihemophilic factor (recombinant), fc-vwf-xten fusion protein-ehtl —	2.9 [1.7–5.2]	12	algemeen	new
amlodipine besylate and olmesartan medoxomil —	4.9 [3.7–6.5]	49	algemeen	new
amiodarone hydrochloride —	5.5 [4.8–6.2]	236	algemeen	new
alteplase —	2.5 [2.1–3.0]	149	algemeen	new

ROR = reporting odds ratio vs. the full FAERS corpus. A signal is not a cause. Source: openFDA (FAERS).